Headlines

Business interruption insurance, an insurance that covers loss of income caused by a disaster, is a way for many businesses to have a sort of life preserver during this disruptive time. But what happens if your insurance claim is denied, ripping your lifeline away and defying the spirit of the bargained for deal you…

Motley Rice LLC is investigating alleged breaches of fiduciary duty by certain World Acceptance Corp. officers and directors for shareholders who purchased stock in the company between May 2017 and the present

A mid-air collision claimed seven lives in Soldotna, Alaska, on July 31, 2020, including four members of a South Carolina family.

While Whistleblower Appreciation Day (7/30) is a time to reflect on the individuals who selflessly come forward with information for the good of us all, it is also a time to examine the ever-changing landscape as our country continues to craft new laws and establish precedent that hopefully will make it easier for…

Legal online publication Law360 recognized medical attorney Ann E. Rice Ervin as one of five 2020 Rising Stars in the area of product liability.

Honeywell International investors who suffered losses in connection with investments between Feb. 9, 2018 and Oct. 19, 2018 may apply for appointment as a Co-Lead Plaintiff no later than Sept. 18, 2020

Johnson & Johnson recently announced it will stop selling talcum-based baby powered in the U.S. and Canada. The decision to stop selling the product came within a few short months of an FDA test that found asbestos in a single lot of J&J baby powder, despite the company’s continued statements that its baby…

USO ETF investors who suffered significant losses in connection with the ETF that invested in crude oil futures contracts may apply for appointment as Lead Plaintiff on August 18, 2020

A $192 million settlement was approved today to resolve shareholder claims that alleged SCANA Corp. and certain of the energy company’s executives violated the Securities Exchange Act.

Updates to the label for Elmiron®, a medication used to treat bladder pain and inflammation, now warn of potential, permanent damage to the retina that could cause irreversible vision loss.